ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 364,05
0,19%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Incannex Healthcare Ltd (IXHL)

  7. Incannex Healthcare Ltd (IXHL) Actualités

IXHL Incannex Healthcare Ltd

2,61
-0,86 (-24,78%)
22 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Incannex Healthcare Ltd IXHL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,86 -24,78% 2,61 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,48 3,35 3,55 3,50 3,47
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/5/202414:30EDGAR2Form 8-K - Current report
30/5/202413:30GLOBEPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial..
07/5/202413:30GLOBEIncannex Complete Successful Pre-IND Meeting with the FDA..
16/4/202414:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/2/202413:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
16/2/202414:00EDGAR2Form 8-K - Current report
16/2/202413:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/2/202412:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202413:30EDGAR2Form 8-K - Current report
01/2/202413:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
24/1/202422:30EDGAR2Form 8-K - Current report
24/1/202422:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
18/1/202415:08EDGAR2Form 8-K - Current report
18/1/202414:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/1/202413:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/1/202412:05EDGAR2Form 8-K - Current report
22/12/202312:07EDGAR2Form 8-K - Current report
22/12/202302:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
20/12/202323:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202313:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
29/11/202319:40GLOBEIncannex Healthcare Announces Completion of..
16/11/202315:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:30GLOBEFederal Court of Australia Approves Incannex’s..
08/11/202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202313:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
08/9/202312:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202314:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202313:30GLOBEIncannex to Prepare FDA IND Application for..
22/8/202313:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
08/8/202314:00GLOBEClarion Clinics Begins Accepting Registrations for..
08/8/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202313:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
26/7/202313:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
21/7/202315:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
18/7/202313:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
13/7/202314:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
13/7/202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202314:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202313:30GLOBEIncannex Announces Intention to Redomicile to United States,..
06/7/202314:42GLOBEIncannex Receives Ethics Approval for..

Dernières Valeurs Consultées

NASDAQ
IXHL
Incannex Healthcare
UNSW3
OPOEETH
Only Possible On Ethereum
NASDAQI
SX5020GI
OMX Stockholm Industrial...
KOSPI
76400004
First Investment Trust 2...
NASDAQ
AAZJQXX
Bofa Finance Llc Capped ...
NASDAQ
ELGX
Endologix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés